EV/EBITDA
-1.57
+0.29+15.59%
Mon, 10 Mar 2025 22:54:29 GMT
Summary
- As of March 11, 2025, ENLV EV/EBITDA is -1.57, with a rise of +0.29 (+15.59%) during the most recent trading day.
- Over the past year, ENLV EV/EBITDA has increased by +1.96 (+55.52%).
- ENLV EV/EBITDA is now -123.75% below its all-time high of 6.61.
Performance
ENLV EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ENLV EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +15.6% | -16.1% | -15.0% |
| 1 m1 month | -10.6% | +10.0% | +9.2% |
| 3 m3 months | +5.4% | -6.0% | -5.6% |
| 6 m6 months | -13.8% | -2.2% | -7.8% |
| ytdytd | -1.9% | +1.9% | +1.7% |
| 1 y1 year | +55.5% | -68.1% | -71.2% |
| 5 y5 years | +82.0% | -67.1% | -79.3% |
ENLV EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -25.6% | -1.86 | +15.6% | |
| 3 m | 3-month | -1.25 | -25.6% | -1.86 | +15.6% |
| 6 m | 6-month | -1.14 | -37.7% | -2.39 | +34.3% |
| 1 y | 1-year | -0.83 | -89.2% | -3.80 | +58.7% |
| 3 y | 3-year | -0.14 | -1021.4% | -5.19 | +69.8% |
| 5 y | 5-year | -0.14 | -1021.4% | -39.00 | +96.0% |
| alltime | all time | 6.61 | -123.8% | -53.73 | +97.1% |
Enlivex Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.57(+1.9%) |
| 2024 | -1.54(-25.6%) |
| 2023 | -2.07(+88.2%) |
| 2022 | -1.10(-81.2%) |
| 2021 | -5.84(-52.8%) |
| 2020 | -12.37(+25.6%) |
| Date | Value |
|---|---|
| 2019 | -9.85(-813.8%) |
| 2018 | 1.38(-170.1%) |
| 2017 | -1.97(+207.8%) |
| 2016 | -0.64(-79.3%) |
| 2015 | -3.09(-72.8%) |
| 2014 | -11.36 |
FAQ
- What is Enlivex Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Enlivex Therapeutics?
- What is ENLV EV/EBITDA year-to-date change?
- What is Enlivex Therapeutics EV/EBITDA year-on-year change?
What is Enlivex Therapeutics EV/EBITDA?
The current EV/EBITDA of ENLV is -1.57
What is the all time high EV/EBITDA for Enlivex Therapeutics?
Enlivex Therapeutics all-time high EV/EBITDA is 6.61
What is ENLV EV/EBITDA year-to-date change?
Enlivex Therapeutics EV/EBITDA has changed by -0.03 (-1.95%) since the beginning of the year
What is Enlivex Therapeutics EV/EBITDA year-on-year change?
Over the past year, ENLV EV/EBITDA has changed by +1.96 (+55.52%)